Close

Bristol-Myers Squibb (BMY) Announces Expanded FDA Approval for Opdivo in NSCLC

October 9, 2015 3:03 PM EDT Send to a Friend
Bristol-Myers Squibb Company (NYSE: BMY) today announced that the U.S. Food and Drug Administration (FDA) has approved Opdivo (nivolumab) injection ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login